REVAFLEX
Dead / Cancelled — Cancelled — Section 8 (as of 18 Mar 2022)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85921705
- Registration number
- 4808970
- Mark type
- Stylized text
- Filed
- 02 May 2013
- Published for opposition
- 22 Oct 2013
- Registered
- 08 Sept 2015
- Attorney of record
- Matthew J. Smith
Goods and services
- Class 005 — Pharmaceuticals: Cell-based therapy for medical use, namely, biological tissue for the stimulation of cartilage growth; cell-based material in the nature of biological tissue for repair and regeneration of cartilage in joints, for example knee, hip and shoulder; cellular tissue and cellular components in the nature of biological tissue for implantation within cartilage for the repair, replacement and growth enhancement of cartilage
Owner
- ISTO Technologies, Inc., St. Louis, MO, US
- ISTO Technologies, Inc., St. Louis, MO, US
- ISTO Technologies, Inc., St. Louis, MO, US
Prosecution history
- 18 Mar 2022 — CANCELLED SEC. 8 (6-YR)
- 08 Sept 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Sept 2015 — EXPARTE APPEAL TERMINATED
- 08 Sept 2015 — REGISTERED-PRINCIPAL REGISTER
- 07 Aug 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Aug 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Aug 2015 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Aug 2015 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Aug 2015 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 05 Aug 2015 — ASSIGNED TO EXAMINER
- 04 Aug 2015 — EX PARTE APPEAL-INSTITUTED
- 04 Aug 2015 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 04 Aug 2015 — EXPARTE APPEAL RECEIVED AT TTAB
- 25 Feb 2015 — ASSIGNED TO EXAMINER
- 04 Feb 2015 — NOTIFICATION OF FINAL REFUSAL EMAILED